dendritic cell vaccine (C5 alpha agonist adjuvant) (University of Nebraska Medical Center)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namedendritic cell vaccine (C5 alpha agonist adjuvant) (University of Nebraska Medical Center)
Drug Alias NameC5a agonist adjuvant-based dendritic cell vaccine (UNMC)
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineBiologics > Antigen > Tumor antigen +[4] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Nebraska Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUNeMed CorpUniversity Of Nebraska Medical Center
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A